Correlation Between Edgewise Therapeutics and GeneDx Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and GeneDx Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and GeneDx Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and GeneDx Holdings Corp, you can compare the effects of market volatilities on Edgewise Therapeutics and GeneDx Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of GeneDx Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and GeneDx Holdings.

Diversification Opportunities for Edgewise Therapeutics and GeneDx Holdings

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Edgewise and GeneDx is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and GeneDx Holdings Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneDx Holdings Corp and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with GeneDx Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneDx Holdings Corp has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and GeneDx Holdings go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and GeneDx Holdings

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the GeneDx Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 4.64 times less risky than GeneDx Holdings. The stock trades about -0.09 of its potential returns per unit of risk. The GeneDx Holdings Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  5,606  in GeneDx Holdings Corp on August 27, 2024 and sell it today you would earn a total of  2,265  from holding GeneDx Holdings Corp or generate 40.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  GeneDx Holdings Corp

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
GeneDx Holdings Corp 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GeneDx Holdings Corp are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain technical and fundamental indicators, GeneDx Holdings unveiled solid returns over the last few months and may actually be approaching a breakup point.

Edgewise Therapeutics and GeneDx Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and GeneDx Holdings

The main advantage of trading using opposite Edgewise Therapeutics and GeneDx Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, GeneDx Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneDx Holdings will offset losses from the drop in GeneDx Holdings' long position.
The idea behind Edgewise Therapeutics and GeneDx Holdings Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges